Search

everythinglearnresearchcommunity

for

Search:↓

A new non-invasive laser system improves chronic disease management and metabolic health.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

ETS2 is crucial in squamous cell carcinoma development and could be a therapeutic target.

Toxic Shock Syndrome cases increased due to new factors, but decreased with public health measures and changes in tampon use.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

Targeted protein degraders show promise in treating cancer but need to target more diverse proteins.

Docetaxel often causes hair loss, with limited effective treatments and no cure for permanent hair loss.

Skin-resident memory T cells may contribute to chronic alopecia areata and baricitinib could be a potential treatment.

Alopecia areata patients have higher levels of certain immune receptors, suggesting new treatment possibilities.

The new gel combining minoxidil and tofacitinib effectively treats alopecia areata by promoting hair growth and reducing inflammation.

A combination of ixekizumab and tofacitinib successfully treated severe scalp cellulitis, leading to hair regrowth.

AHCC reduces hair loss and liver injury caused by chemotherapy in rodents.

Temporary scalp trichopigmentation creates a shaved hair look on the scalp using pigments that fade over time.

The study helps doctors use patient images to understand and apply SALT scores for treating severe alopecia areata.

Understanding how Regulatory T Cells work could help create treatments for certain skin diseases and cancers.

Microneedle arrays deliver botulinum toxin effectively for sweat suppression, similar to injections.

Treg cells help repair and regenerate tissues by interacting with local cells.

Generic topical and transdermal systems usually cause minimal irritation or sensitization.

Intralesional triamcinolone acetonide is effective and safe for treating early to mid-stage traction alopecia.

Oral dexamethasone may help regrow hair in adults with alopecia totalis and universalis.

Temporal triangular alopecia usually starts in early childhood and treatment with Minoxidil has limited effectiveness.

Congenital triangular alopecia is a hair loss condition present from birth or early childhood with no effective treatment needed.

Scientists found a new type of skin cell that could help with skin repair and these cells work better with a certain protein.

Congenital triangular alopecia can occur outside the typical fronto-temporal region.

Trichoscopy effectively diagnoses and monitors treatment in children with tinea capitis.

A new hair loss treatment using dissolving microneedles was found to speed up hair growth and was more effective than daily use of common hair growth drugs.

Combining scalp acupoint catgut embedding with 5% minoxidil may help treat male pattern baldness.

Tofacitinib may cause nerve damage in the brain, so monitor for neurological symptoms.

Regulatory T cells adapt to different environments to control inflammation and support tissue repair.